Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Abatacept in ANCA Associated Vasculitis (ABAVAS)

This study has been terminated.
(Funders withdrew funding due to slow recruitment)
Sponsor:
Collaborator:
Bristol-Myers Squibb
Information provided by:
Imperial College London
ClinicalTrials.gov Identifier:
NCT00482066
First received: June 1, 2007
Last updated: May 25, 2010
Last verified: May 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2010
  Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)